Clinical trials at Charlotte Maxeke Johannesburg Academic Hospital and Chris Hani Baragwanath Hospital were conducted for both devices.
Manufacture of the 2 000 SAVE-P CPAP 100 blenders was concluded in October 2020 and the 18 000 CSIR L.I.F.E blenders in November 2020. In addition to the 20 000 blenders, 63 000 patient circuits were also required. All 63 000 patient circuits were complete by February 2021, with production scheduled according to deployment of the units.
Assembly, testing and packaging for the CSIR L.I.F.E devices was conducted at Akacia Medical, and at MCR Manufacturing for the SAVE-P CPAP 100 units.
Average cost for the CSIR L.I.F.E blenders was initially in the region of R5 000 per unit. Further to achieving economies of scale in the production process, these unit costs have now been reduced to approximately R1 500.
The SAVE-P CPAP 100 blenders are entirely different units with distinct functionality and cost in the region of R17 000 per unit.
Patient circuits for both blenders are in the region of R1 500.